Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells.

Han YY, Liu HY, Han DJ, Zong XC, Zhang SQ, Chen YQ.

Biochem Pharmacol. 2013 Nov 1;86(9):1254-62. doi: 10.1016/j.bcp.2013.08.008. Epub 2013 Aug 17.

PMID:
23962446
2.

Gangliosides and N-glycoproteins function as Newcastle disease virus receptors.

Ferreira L, Villar E, Muñoz-Barroso I.

Int J Biochem Cell Biol. 2004 Nov;36(11):2344-56.

PMID:
15313478
3.

Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.

Hilchie AL, Doucette CD, Pinto DM, Patrzykat A, Douglas S, Hoskin DW.

Breast Cancer Res. 2011 Oct 24;13(5):R102. doi: 10.1186/bcr3043.

4.

Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.

Shahin M, Soudy R, Aliabadi HM, Kneteman N, Kaur K, Lavasanifar A.

Biomaterials. 2013 May;34(16):4089-97. doi: 10.1016/j.biomaterials.2013.02.019. Epub 2013 Mar 5.

PMID:
23465829
5.

Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide.

Lee HS, Park CB, Kim JM, Jang SA, Park IY, Kim MS, Cho JH, Kim SC.

Cancer Lett. 2008 Nov 18;271(1):47-55. doi: 10.1016/j.canlet.2008.05.041. Epub 2008 Jul 9.

PMID:
18617323
6.

Riccardin D, a macrocyclic bisbibenzy, inhibits human breast cancer growth through the suppression of telomerase activity.

Sun CC, Xu HM, Yuan Y, Gao ZH, Lou HX, Qu XJ.

Basic Clin Pharmacol Toxicol. 2014 Dec;115(6):488-98. doi: 10.1111/bcpt.12267. Epub 2014 Jun 6.

7.

Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.

Pousset D, Piller V, Bureaud N, Monsigny M, Piller F.

Cancer Res. 1997 Oct 1;57(19):4249-56.

8.

Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides.

Müthing J, Burg M, Möckel B, Langer M, Metelmann-Strupat W, Werner A, Neumann U, Peter-Katalinic J, Eck J.

Glycobiology. 2002 Aug;12(8):485-97.

PMID:
12145189
9.

Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.

Wang X, Yuan S, Wang J, Lin P, Liu G, Lu Y, Zhang J, Wang W, Wei Y.

Toxicol Appl Pharmacol. 2006 Sep 1;215(2):168-78. Epub 2006 Mar 23.

PMID:
16563451
10.

The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.

Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.

Breast Cancer Res Treat. 2012 Apr;132(2):449-61. doi: 10.1007/s10549-011-1585-0. Epub 2011 Jun 3.

PMID:
21638053
11.

Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.

Hou L, Zhao X, Wang P, Ning Q, Meng M, Liu C.

PLoS One. 2013;8(1):e53491. doi: 10.1371/journal.pone.0053491. Epub 2013 Jan 11.

12.

In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.

Wang W, Rayburn ER, Velu SE, Nadkarni DH, Murugesan S, Zhang R.

Clin Cancer Res. 2009 May 15;15(10):3511-8. doi: 10.1158/1078-0432.CCR-08-2689.

13.

Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.

Chun J, Kim YS.

Chem Biol Interact. 2013 Oct 5;205(3):212-21. doi: 10.1016/j.cbi.2013.07.002. Epub 2013 Jul 16.

PMID:
23867902
14.

Anticancer peptide NK-2 targets cell surface sulphated glycans rather than sialic acids.

Gross S, Andrä J.

Biol Chem. 2012 Aug;393(8):817-27. doi: 10.1515/hsz-2012-0136.

PMID:
22944683
15.

Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.

Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB.

Cancer Res. 1996 Dec 1;56(23):5319-24.

16.

Antimicrobial cyclic decapeptides with anticancer activity.

Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T.

Peptides. 2010 Nov;31(11):2017-26. doi: 10.1016/j.peptides.2010.07.027. Epub 2010 Aug 11.

PMID:
20708052
17.

Enantiomeric CopA3 dimer peptide suppresses cell viability and tumor xenograft growth of human gastric cancer cells.

Lee JH, Kim IW, Shin YP, Park HJ, Lee YS, Lee IH, Kim MA, Yun EY, Nam SH, Ahn MY, Kang D, Hwang JS.

Tumour Biol. 2016 Mar;37(3):3237-45. doi: 10.1007/s13277-015-4162-z. Epub 2015 Oct 2.

PMID:
26432335
18.

Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).

Wang C, Li HB, Li S, Tian LL, Shang DJ.

Biochimie. 2012 Feb;94(2):434-41. doi: 10.1016/j.biochi.2011.08.011. Epub 2011 Aug 23.

PMID:
21871946
19.

Efficacy of a proapoptotic peptide towards cancer cells.

Jäkel CE, Meschenmoser K, Kim Y, Weiher H, Schmidt-Wolf IG.

In Vivo. 2012 May-Jun;26(3):419-26.

PMID:
22523294
20.

Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.

Harvey KA, Xu Z, Saaddatzadeh MR, Wang H, Pollok K, Cohen-Gadol AA, Siddiqui RA.

J Neurosurg. 2015 Mar;122(3):547-56. doi: 10.3171/2014.10.JNS14759. Epub 2014 Dec 19.

PMID:
25526274

Supplemental Content

Support Center